Key terms
About PBM
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on June 29, 2023 and is headquartered in Toronto, Canada.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PBM news
Apr 17
8:15am ET
Psyence Biomedical announces Phase IIb trial listing on ANZCTR
Apr 08
8:22am ET
Psyence Biomedical partners with Fluence, iNGENu to train research therapists
Mar 12
7:25am ET
Psyence Biomedical says ‘foundation in place’ to be R&D leader in psilocybin
Mar 11
7:35am ET
Psyence Group provides update following spin out of therapeutic unit
Mar 06
7:17am ET
Psyence Biomedical’s Psyence Australia receives HREC approval
No recent press releases are available for PBM
PBM Financials
Key terms
Ad Feedback
PBM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PBM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
